Julio Benites Selected Research

2-(4-hydroxyanilino)-1,4-naphthoquinone

1/2016

In vivo inhibition of tumor progression by 5 hydroxy-1,4-naphthoquinone (juglone) and 2-(4-hydroxyanilino)-1,4-naphthoquinone (Q7) in combination with ascorbate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Benites Research Topics

Disease

13	Neoplasms (Cancer) 02/2020 - 06/2009
2	Carcinoma (Carcinomatosis) 01/2015 - 09/2012
2	Adenocarcinoma 01/2014 - 09/2012
2	Hepatocellular Carcinoma (Hepatoma) 06/2009 - 09/2008
1	Hypoxia (Hypoxemia) 01/2016
1	Leukemia 01/2014
1	Lung Neoplasms (Lung Cancer) 09/2012

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 02/2020 - 12/2010
3	Proteins (Proteins, Gene)FDA Link 02/2020 - 01/2012
3	QuinonesIBA 02/2020 - 10/2011
3	NaphthoquinonesIBA 01/2020 - 07/2014
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2020 - 01/2016
2	Amino Acids FDA Link 12/2017 - 09/2016
2	jugloneIBA 01/2016 - 01/2015
2	Biological ProductsIBA 07/2014 - 09/2008
2	Adenosine Triphosphate (ATP)IBA 10/2011 - 06/2009
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2009 - 09/2008
1	EnzymesIBA 01/2016
1	2-(4-hydroxyanilino)-1,4-naphthoquinoneIBA 01/2016
1	Acridine OrangeIBA 01/2016
1	Adenosine Diphosphate (ADP)IBA 01/2016
1	AntioxidantsIBA 01/2016
1	Ethidium (Ethidium Bromide)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Cyclin AIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014
1	Etoposide (VP 16)FDA LinkGeneric 01/2014
1	Caspase 3 (Caspase-3)IBA 10/2011
1	Oxidants (Oxidizing Agents)IBA 06/2009
1	2-euryfuryl-1,4-naphthoquinoneIBA 06/2009
1	SesquiterpenesIBA 09/2008
1	quinone (benzoquinone)IBA 09/2008

Therapy/Procedure

1	Therapeutics 10/2011